Pharmacology, Toxicology and Pharmaceutical Science
Epirubicin
94%
Multidrug Resistance
57%
Nanoparticle
51%
Liposome
40%
microRNA
29%
Epidermal Growth Factor Receptor
29%
Neoplasm
28%
Afatinib
22%
Malignant Neoplasm
19%
Acrolein
19%
Cytotoxicity
19%
Colorectal Carcinoma
17%
Tumor Microenvironment
15%
Head and Neck Cancer
15%
Messenger RNA
15%
Macrogol
14%
Reactive Oxygen Metabolite
14%
P-Glycoprotein
12%
Effusion
12%
Anticarcinogen
12%
Sustained Release
11%
Poloxamer
11%
Multidrug Resistance Protein 1
11%
Solid Lipid Nanoparticle
11%
Multidrug Resistance-Associated Protein 2
11%
Multidrug Resistance Associated Protein 1
10%
Polypeptide Antibiotic Agent
10%
Colon Adenocarcinoma
10%
Polyacrylic Acid
10%
Neurotoxicity
10%
Nervous System Inflammation
10%
Uterine Cervix Cancer
9%
Immunologic Adjuvant
9%
Pancreas Cancer
9%
Tilapia
9%
Pilocarpine
9%
Chitosan
9%
Antisense Oligonucleotide
9%
Antiinflammatory Activity
9%
Dopamine Receptor Stimulating Agent
9%
Neuroprotective Agent
9%
Polyethylene Glycol
9%
Blood-Brain Barrier
9%
Tween 80
9%
Hepcidin
8%
Irinotecan
8%
Squamous Cell Carcinoma
8%
Cell Penetrating Peptide
8%
Pancreas Adenocarcinoma
7%
Interleukin 4
7%
Keyphrases
Epirubicin
100%
Caco-2 Cells
40%
Multidrug Resistance
35%
Liposomes
30%
MicroRNA
29%
Nanoparticles
28%
Afatinib
24%
Apoptosis
19%
Acrolein
19%
Induced Apoptosis
17%
Multidrug Resistance Reversal
16%
Cytotoxicity
16%
Anticancer Drugs
15%
Head-and-neck Cancer
15%
PH-sensitive
15%
Acrylic Acid
14%
Phosphatidylglycerol
14%
Multidrug Resistance Protein 1 (MDR1)
14%
Fourier Transform Infrared Spectroscopy (FT-IR)
13%
Pluronic
13%
Superoxide Dismutase
13%
Targeting Peptide
13%
Liposomal
13%
Differential Scanning Calorimetry
12%
HeLa Cells
11%
Catenin
11%
Co-treatment
11%
PEGylated Liposomes
11%
Multidrug Resistance-associated Protein 2 (MRP2)
11%
Rat Intestine
11%
Reactive Oxygen Species Production
11%
Everted Gut Sac
11%
Sustained Release
10%
Epidermal Growth Factor Receptor
10%
P-glycoprotein (P-gp)
10%
Intestinal Epithelial Cells
10%
Interleukin-4 (IL-4)
10%
Tumor Microenvironment
10%
Nanoformulation
10%
Neurotoxicity
10%
Antimicrobial Peptides
10%
Polyethylene Glycol
10%
B-cell Lymphoma 2 (Bcl-2)
10%
Neuroinflammation
10%
Liposomal Formulation
9%
MicroRNA-125b
9%
CRMP2
9%
Intralipid
9%
Tilapia
9%
Oxygen-glucose Deprivation
9%
Biochemistry, Genetics and Molecular Biology
Epirubicin
53%
Programmed Cell Death
26%
Multidrug Resistance
26%
Lipid
14%
P-Glycoprotein
12%
Cytotoxicity
11%
Messenger RNA
10%
Mediator
9%
Semaphorin
9%
Colon
9%
Superoxide Dismutase
8%
Epidermal Growth Factor Receptor
8%
Cancer Cell
7%
Anticancer
7%
Catenin
7%
Differential Scanning Calorimetry
7%
Phospholipid
7%
Galectin-3
6%
Infrared Radiation
6%
Cell Death
6%
Cytochrome C
6%
Ribonuclease A
6%
Daidzein
5%
Thermostability
5%
Mitochondrial DNA
5%
Endoplasmic Reticulum Stress
5%
Absorption
5%
Homeostasis
5%
GSK-3
5%
Conformational Change
5%
Glucose Transport
5%
Adipocyte
5%